The Nigeria Centre for Disease Control (NCDC) has reported a decline in the number of suspected and confirmed monkeypox cases in the country over the past four weeks.
Mpox is an infectious viral disease that can occur in humans and other animals. Symptoms include a rash that forms blisters, fever and swollen lymph nodes. The illness is usually mild, and most infected individuals recover within a few weeks without treatment.
According to NCDC’s latest data on its official website on Monday, 51 new suspected cases were reported between Epidemiological (Epi) weeks 29 to 32 of 2024.
The public health agency noted there was a significant drop from the 102 cases reported during the previous four weeks (Epi Week 25 to 28). It said that these cases were recorded across 26 local government areas (LGAs) in 18 states.
The agency said that out of the new suspected cases, two were confirmed positive, with one case each reported in Ebonyi and Enugu. It said that this also marked a decrease from the seven confirmed cases recorded in the earlier period.
“The following outlined case definitions for suspected mpox case are an acute illness with fever 38.3°C, intense headache, lymphadenopathy, back pain, and myalgia.
“Intense asthenia follows one to three days later by a progressively developing rash often beginning on the face and spreading to other parts of the body,” it said.
It described probable case as a case that meets the clinical case definition, is not laboratory-confirmed but has an epidemiological link to a confirmed case.
Read also: Nigeria records 39 Mpox cases, eyes 10,000 vaccine doses
“A confirmed case is a clinically compatible case that is laboratory-confirmed.
“Contact is any person who has been in direct or indirect contact with a confirmed case since the onset of symptoms,” it said.
The NCDC highlighted that in 2024 alone, mpox had been confirmed in 19 states and the Federal Capital Territory (FCT), affecting 30 Local Government Areas.
“Since the resurgence of mpox in Nigeria in September 2017, the country has seen a cumulative total of 4,603 suspected cases, with 1,125 confirmed cases (24.4%) across 35 states and the FCT.
“The disease has disproportionately affected males, who account for approximately 70 percent of confirmed cases. Seventeen deaths have been recorded since 2017,” it said.
It said that the Case Fatality Rate for mpox was calculated based on confirmed cases only.
To prevent the spread of mpox, the NCDC advised the public to avoid close contact with individuals showing symptoms, particularly those with rashes or skin lesions.
“Practice good hand hygiene by regularly washing hands with soap and water or using an alcohol-based hand sanitiser. Wear protective gear (gloves, masks) when caring for someone with suspected or confirmed mpox”, it advised.
